These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 30975575)

  • 21. Presenilin E318G variant and Alzheimer's disease risk: the Cache County study.
    Hippen AA; Ebbert MT; Norton MC; Tschanz JT; Munger RG; Corcoran CD; Kauwe JS
    BMC Genomics; 2016 Jun; 17 Suppl 3(Suppl 3):438. PubMed ID: 27357204
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association between Apolipoprotein E Gene Polymorphism and Alzheimer's Disease in an Iranian Population: A Meta-Analysis.
    Abyadeh M; Djafarian K; Heydarinejad F; Alizadeh S; Shab-Bidar S
    J Mol Neurosci; 2019 Dec; 69(4):557-562. PubMed ID: 31444704
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Apolipoprotein E genotypes and plasma levels in mild cognitive impairment conversion to Alzheimer's disease: A follow-up study.
    Scarabino D; Broggio E; Gambina G; Maida C; Gaudio MR; Corbo RM
    Am J Med Genet B Neuropsychiatr Genet; 2016 Dec; 171(8):1131-1138. PubMed ID: 27604972
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic associations between cathepsin D exon 2 C-->T polymorphism and Alzheimer's disease, and pathological correlations with genotype.
    Davidson Y; Gibbons L; Pritchard A; Hardicre J; Wren J; Tian J; Shi J; Stopford C; Julien C; Thompson J; Payton A; Thaker U; Hayes AJ; Iwatsubo T; Pickering-Brown SM; Pendleton N; Horan MA; Burns A; Purandare N; Lendon CL; Neary D; Snowden JS; Mann DM
    J Neurol Neurosurg Psychiatry; 2006 Apr; 77(4):515-7. PubMed ID: 16543533
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic variation in 3-hydroxy-3-methylglutaryl CoA reductase modifies the chemopreventive activity of statins for colorectal cancer.
    Lipkin SM; Chao EC; Moreno V; Rozek LS; Rennert H; Pinchev M; Dizon D; Rennert G; Kopelovich L; Gruber SB
    Cancer Prev Res (Phila); 2010 May; 3(5):597-603. PubMed ID: 20403997
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacogenetic study of statin therapy and cholesterol reduction.
    Chasman DI; Posada D; Subrahmanyan L; Cook NR; Stanton VP; Ridker PM
    JAMA; 2004 Jun; 291(23):2821-7. PubMed ID: 15199031
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of complement factor H Y402H gene polymorphism with Alzheimer's disease.
    Zetterberg M; Landgren S; Andersson ME; Palmér MS; Gustafson DR; Skoog I; Minthon L; Thelle DS; Wallin A; Bogdanovic N; Andreasen N; Blennow K; Zetterberg H
    Am J Med Genet B Neuropsychiatr Genet; 2008 Sep; 147B(6):720-6. PubMed ID: 18163432
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A meta-analysis of Italian and Estonian individuals shows an effect of common variants in
    Rosticci M; Pervjakova N; Kaakinen M; Cicero AF; Feufer AP; Marullo L; Mägi R; Fischer K; Jiang L; D'Addato S; Rizzoli E; Massimo G; Giovannini M; Angelini S; Hrelia P; Scapoli C; Borghi C; Prokopenko I
    Biomark Med; 2019 Aug; 13(11):931-940. PubMed ID: 30191727
    [No Abstract]   [Full Text] [Related]  

  • 29. Identification of novel quantitative traits-associated susceptibility loci for APOE ε 4 non-carriers of Alzheimer's disease.
    Jiang S; Yang W; Qiu Y; Chen HZ;
    Curr Alzheimer Res; 2015; 12(3):218-27. PubMed ID: 25731621
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polymorphism in the cholesterol 24S-hydroxylase gene (CYP46A1) associated with the APOEpsilon3 allele increases the risk of Alzheimer's disease and of mild cognitive impairment progressing to Alzheimer's disease.
    Fernández Del Pozo V; Alvarez Alvarez M; Fernández Martínez M; Galdós Alcelay L; Gómez Busto F; Peña JA; Alfonso-Sánchez MA; Zarranz Imirizaldu JJ; de Pancorbo MM
    Dement Geriatr Cogn Disord; 2006; 21(2):81-7. PubMed ID: 16340204
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between Cerebrospinal Fluid Biomarkers for Alzheimer's Disease, APOE Genotypes and Auditory Verbal Learning Task in Subjective Cognitive Decline, Mild Cognitive Impairment, and Alzheimer's Disease.
    Mandecka M; Budziszewska M; Barczak A; Pepłońska B; Chodakowska-Żebrowska M; Filipek-Gliszczyńska A; Nesteruk M; Styczyńska M; Barcikowska M; Gabryelewicz T
    J Alzheimers Dis; 2016 Jul; 54(1):157-68. PubMed ID: 27472875
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The genetic risk of Alzheimer's disease beyond APOE ε4: systematic review of Alzheimer's genetic risk scores.
    Stocker H; Möllers T; Perna L; Brenner H
    Transl Psychiatry; 2018 Aug; 8(1):166. PubMed ID: 30143603
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
    Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
    JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interactions Among Polymorphisms of Susceptibility Loci for Alzheimer's Disease or Depressive Disorder.
    Kitzlerová E; Fišar Z; Lelková P; Jirák R; Zvěřová M; Hroudová J; Manukyan A; Martásek P; Raboch J
    Med Sci Monit; 2018 Apr; 24():2599-2619. PubMed ID: 29703883
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ε3/4 genotype of the apolipoprotein E is associated with higher risk of Alzheimer's disease in patients with type 2 diabetes mellitus.
    Tang Y; Li YM; Zhang M; Chen YQ; Sun Q
    Gene; 2019 Jun; 703():65-70. PubMed ID: 30890475
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cerebrospinal fluid beta-amyloid1-42 and tau in control subjects at risk for Alzheimer's disease: the effect of APOE epsilon4 allele.
    Sunderland T; Mirza N; Putnam KT; Linker G; Bhupali D; Durham R; Soares H; Kimmel L; Friedman D; Bergeson J; Csako G; Levy JA; Bartko JJ; Cohen RM
    Biol Psychiatry; 2004 Nov; 56(9):670-6. PubMed ID: 15522251
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of COMT Val158Met polymorphism on Alzheimer's disease and mild cognitive impairment in Italian patients.
    Lanni C; Garbin G; Lisa A; Biundo F; Ranzenigo A; Sinforiani E; Cuzzoni G; Govoni S; Ranzani GN; Racchi M
    J Alzheimers Dis; 2012; 32(4):919-26. PubMed ID: 22890094
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacogenetic Analyses of Therapeutic Effects of Lipophilic Statins on Cognitive and Functional Changes in Alzheimer's Disease.
    de Oliveira FF; Bertolucci PHF; Chen ES; Smith MC
    J Alzheimers Dis; 2022; 87(1):359-372. PubMed ID: 35311709
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic risk score modifies the effect of APOE on risk and age onset of Alzheimer's disease.
    Shi Z; Yu H; Wu Y; Ford M; Perschon C; Wang C; Zheng SL; Xu J
    Clin Genet; 2019 Feb; 95(2):302-309. PubMed ID: 30460685
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gene-gene interactions among coding genes of iron-homeostasis proteins and APOE-alleles in cognitive impairment diseases.
    Tisato V; Zuliani G; Vigliano M; Longo G; Franchini E; Secchiero P; Zauli G; Paraboschi EM; Vikram Singh A; Serino ML; Ortolani B; Zurlo A; Bosi C; Greco A; Seripa D; Asselta R; Gemmati D
    PLoS One; 2018; 13(3):e0193867. PubMed ID: 29518107
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.